Search results (10)
« Back to PublicationsBCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs.
Journal article
Ng HL. et al, (2026), Adv Sci (Weinh)
Ph+B-ALL is defined by BCR::ABL1-induced enhancer reprogramming and hypersensitivity to enhancer-targeting drugs
Preprint
Ng* HL. et al, (2025)
Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillation.
Journal article
Vyas V. et al, (2024), Nat Cardiovasc Res, 3, 1067 - 1082
Promoter-centred chromatin interactions associated with EVI1 expression in EVI1+3q- myeloid leukaemia cells.
Journal article
Ng HL. et al, (2024), Br J Haematol, 204, 945 - 958
To Be, or Notch to Be: Mediating Cell Fate from Embryogenesis to Lymphopoiesis.
Journal article
Ng HL. et al, (2021), Biomolecules, 11
Notch signaling induces a transcriptionally permissive state at the Complement C3d Receptor 2 (CR2) promoter in a pre-B cell model.
Journal article
Ng HL. et al, (2020), Mol Immunol, 128, 150 - 164
Disease-associated missense variants in ZBTB18 disrupt DNA binding and impair the development of neurons within the embryonic cerebral cortex.
Journal article
Hemming IA. et al, (2019), Hum Mutat, 40, 1841 - 1855
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
Journal article
Zhao J. et al, (2016), Ann Rheum Dis, 75, 242 - 252
Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.
Journal article
Taylor RL. et al, (2016), Cell Mol Immunol, 13, 119 - 131
